Sapropterin Dipharma
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sapropterin Dipharma, covering 2026-02-03 to 2026-02-03. Get the full timeline:
Most recent: EMA Authorised: Sapropterin Dipharma (sapropterin dihydrochloride) — Dipharma Arzneimittel GmbH